Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportEducational Exhibits - Oncology

Splenic lesions on PET CT : A case series

Raksha Kulkarni and Reema Goel
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241878;
Raksha Kulkarni
1Icahn School of Medicine At Mount Sinai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reema Goel
2Mount Sinai School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

241878

Introduction: Splenic lesions are rare, usually detected incidentally in asymptomatic patients. Imaging characteristics are therefore crucial for decision-making. We present 4 cases highlighting the role of PET CT in evaluating splenic lesions.

Methods: Case 1. A 77-year-old male presented with abdominal pain in 2021.18F-FDG PET-CT revealed multiple hypermetabolic foci in the enlarged spleen and multiple hypermetabolic lymph nodes. Biopsy revealed follicular lymphoma. A post-treatment 18F-FDG PET-CT in January 2024 demonstrated complete resolution of splenic lesions but new hypermetabolic lymph nodes (Figure 1).

Case 2. A 52-year-old female with a history of serous papillary uterine tumor surgically managed in 2002 presented with abdominal pain in 2023. 18FDG PET-CT showed a splenic mass with hypermetabolic calcified nodules and lymph nodes (fig. 2). Surgical pathology revealed moderately differentiated metastases in the spleen containing psammoma bodies, lymph nodes, and pancreatic tail. Immunostains were positive for gynecologic malignancy. Case 3. A 39-year-old male with a history of testicular seminoma, status post orchiectomy was detected with splenic masses on surveillance CT in February 2023 which appear enlarged on a CT in September 2023. 18F-FDG PET-CT demonstrated hypermetabolic hypoattenuating splenic lesions and hypermetabolic retroperitoneal nodes (Figure 3). Fine needle biopsy of the spleen revealed a granulomatous lesion. Case 4: A 55-year-old male underwent a laparoscopic spleen-sparing distal pancreatectomy for a pancreatic neuroendocrine tumor (NET). The postoperative 68Ga DOTATATE PET-CT showed central splenic photopenia corresponding to hypoattenuation on contrast-enhanced CT and peripheral tracer avid tissue suspicious for malignancy. (Figure 4).

Results: The spleen contains lymphocyte-rich white pulp centrally and red pulp rich in venous sinuses peripherally. Hemangiomas are the most common benign tumors of the spleen and lymphoma is the most common malignancy. 18F-FDG PET-CT narrows the vast differentials for splenic masses.18F-FDG avid lesions are primarily infectious/granulomatous lesions, metastases, and primary malignancies. The high avidity of 68Ga DOTATATE for somatostatin receptor-expressing tissues leads to equivocal findings in somatostatin receptor-rich organs. Lymphomatous involvement of the spleen can manifest as splenomegaly, diffuse infiltration, multiple nodules, and rarely as solitary nodules.

In Case 1, hypermetabolic lesions in the enlarged spleen and hypermetabolic lymph nodes on both sides of the diaphragm were suggestive of lymphoma.

Despite its high vascularity, splenic metastases are rare with only about 7% of patients with advanced cancers developing splenic metastases, likely due to an unfavorable internal milieu. Splenic metastases are most commonly from breast, lung, and ovarian cancer, melanoma, and colon cancer. The most common findings are a hypoattenuating lesion with rare calcifications and enhancement.

Uterine papillary serous adenocarcinoma may contain calcifying psammoma bodies. 18FDG avid calcified splenic lesions and retroperitoneal lymph nodes in case 2 were therefore suspicious for metastases as opposed to granulomatous/infectious pathology.

In case 3 the presence of retroperitoneal lymph nodes and enlarging splenic nodules increases the suspicion of metastases since 9-11% of patients with seminomas develop atypical metastases. However, tissue sampling revealed granulomatous disease.

2-5% of patients develop splenic infarcts following spleen-sparing pancreatectomies majority of which are asymptomatic. Non-enhancing hypoattenuating areas denote infarction on CT. In case 4, 68Ga DOTATATE avid tissue around the non-functioning spleen is suspicious of malignancy. The location of the tracer avid tissue, negative surgical margins, and MRI features favored residual splenic tissue.

Conclusions: PET CT is crucial for oncologic decision-making and directs further evaluation, especially with rare presentations.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Splenic lesions on PET CT : A case series
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Splenic lesions on PET CT : A case series
Raksha Kulkarni, Reema Goel
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241878;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Splenic lesions on PET CT : A case series
Raksha Kulkarni, Reema Goel
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241878;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Advances in Therapeutic Managements in Lymphoma and the Role of FDG-PET/CT in Therapeutic Decision-Making
  • 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Review of Treatment Workflow and Challenging Clinical Scenarios
  • Imaging biomarkers for response assessment in Neuroendocrine tumors and role of dual tracer imaging
Show more Educational Exhibits - Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire